Categories: World

GSK – PRESENTS POSITIVE DATA TO EXPAND JIDEYTRO TO FIRST-LINE ROS1-POSITIVE NSCLC

GSK – PRESENTS POSITIVE DATA TO EXPAND JIDEYTRO TO FIRST-LINE ROS1-POSITIVE NSCLC(The article has been published through a syndicated feed. Except for the headline, the content has been…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: September 14, 2026 05:27:05 IST

GSK – PRESENTS POSITIVE DATA TO EXPAND JIDEYTRO TO FIRST-LINE ROS1-POSITIVE NSCLC

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: September 14, 2026 05:27:05 IST

Recent Posts

UPDATE 17-NCAAF Results

Nov 7 (Stats Perform) - Results from the NCAAF games on Saturday (home team in…

November 8, 2026

Maresca bemoans City's lack of intensity after third straight Premier League  defeat

VIDEO SHOWS: PRESS CONFERENCE WITH MANCHESTER CITY MANAGER, ENZO MARESCA SHOWS: NOTTINGHAM, ENGLAND, UK (NOVEMBER…

November 8, 2026

Brazil's CSN strikes deal to sell cement arm to China's Huaxin, says newspaper

BRASILIA, Nov 7 (Reuters) - Brazilian steelmaker CSN signed an agreement on Saturday to sell…

November 8, 2026